Clinical Scorecard: Comparative Analysis of Bariatric Surgery Outcomes in Young Adults and Adults: A Population-Based Cohort Study
At a Glance
Category
Detail
Condition
Severe obesity and obesity-related comorbidities
Key Mechanisms
Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) bariatric procedures
Target Population
Young adults (18–25 years) and adults (35–55 years) undergoing bariatric surgery
Care Setting
Multidisciplinary bariatric surgical centers in the Netherlands
Key Highlights
Bariatric surgery is effective for severe obesity and related comorbidities in both young adults and adults.
Young adults may experience superior weight loss compared to adults up to five years postoperatively after RYGB.
Serious adverse events (Clavien-Dindo ≥ 3b) are more prevalent in young adults between 6 weeks and 5 years post-RYGB.
Guideline-Based Recommendations
Diagnosis
Eligibility assessed per Dutch guideline: BMI ≥ 40 kg/m2 or BMI ≥ 35 kg/m2 with obesity-related comorbidity.
Multidisciplinary team evaluation required before surgery.
Management
Primary bariatric procedures include Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG).
Monitor weight loss outcomes annually for up to five years post-surgery.
Consider age-specific risks and benefits when recommending surgery.
Monitoring & Follow-up
Assess percentage total weight loss (%TWL) annually from one to five years postoperatively.
Monitor for perioperative and postoperative complications using Clavien-Dindo classification.
Evaluate obesity-related comorbidities status (cured, improved, equal, worsened) up to two years post-surgery.
Risks
Higher prevalence of serious adverse events (Clavien-Dindo ≥ 3b) in young adults post-RYGB.
Potential for weight regain defined as ≥ 20% regain of lost weight after initial successful weight loss.
Surgery-related complications may be equal or higher in young adults compared to adults.
Patient & Prescribing Data
Young adults aged 18–25 years and adults aged 35–55 years undergoing primary RYGB or SG.
Young adults show superior weight loss outcomes but may have increased serious adverse events post-RYGB; SG outcomes were also studied but excluded in some analyses.
Clinical Best Practices
Use multidisciplinary evaluation to determine surgical eligibility based on BMI and comorbidities.
Prefer longitudinal follow-up for weight loss and comorbidity status up to five years post-surgery.
Apply Clavien-Dindo classification to systematically assess and report surgical complications.
Consider age-specific counseling regarding benefits and risks of bariatric surgery.
Monitor for weight regain and manage accordingly to sustain long-term weight loss.
